Kiora Pharmaceuticals (KPRX) Misses Q2 EPS by 53c

Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.53).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Needham Reiterates Buy Rating on Veeva Systems (VEEV)
• USA Rare Earth secures $1.55 billion SPV for Serra Verde offtake